Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event.

Pach, Jolanta; Moody, Katherine; Ring, Nan; Panse, Gauri; Zhang, Michael; Deverapalli, Sandhya; Leventhal, Jonathan

Pach, Jolanta; Moody, Katherine; Ring, Nan; Panse, Gauri; Zhang, Michael; Deverapalli, Sandhya; Leventhal, Jonathan.

Afiliación

Pach J; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Moody K; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts.
Ring N; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Panse G; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
Zhang M; Inform Diagnostics, Needham, Massachusetts.
Deverapalli S; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts.
Leventhal J; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

JAAD Case Rep ; 13: 118-120, 2021 Jul.

Article en En | MEDLINE | ID: mdl-34189226

Palabras clave

EN, erythema nodosum; ICPi, immune checkpoint inhibitor; erythema nodosum; immune checkpoint inhibitors; immune-related adverse event; panniculitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google